Alice P. Chen

Treatment of HCV Infection by Targeting MicroRNA

Harry L.A. Janssen, Hendrik W. Reesink, Eric Lawitz et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

RECIST 1.1—Update and clarification: From the RECIST committee

Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer · 2016 · 1.8K citations

Public Policy, Recist 1.1—Update, Law +2

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

M. Catherine Pietanza, Saiama N. Waqar, Lee M. Krug et al. · Journal of Clinical Oncology · 2018 · 387 citations · Full text

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation

Eileen M. O’Reilly, Jonathan W. Lee, Mark M. Zalupski et al. · Journal of Clinical Oncology · 2020 · 383 citations · Full text

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

Alice P. Chen, Ann Setser, Milan J. Anadkat et al. · Journal of the American Academy of Dermatology · 2012 · 349 citations

Dermatologic Adverse Events, Cancer Treatments, Medicine +10